Comorbidities of overweight/obesity in Australian preschoolers: a cross-sectional population study

M Wake1, P Hardy, M G Sawyer

  • 1Centre for Community Child Health, Royal Children's Hospital, Flemington Road, Parkville, VIC 3052, Australia. melissa.wake@rch.org.au

Insights

Parents reported few additional health burdens for overweight preschoolers, despite high prevalence. Parental concern about child weight was low, even for obese children, and unrelated to health issues.

Area of Science:

  • Pediatric Health
  • Obesity Research
  • Public Health

Background:

  • Childhood obesity is a growing public health concern.
  • Understanding parental perception of health in relation to child body mass index (BMI) is crucial.

Purpose of the Study:

  • To examine the association between body mass index (BMI) status and health indicators in Australian preschoolers.
  • To investigate parental concern regarding child weight and its relation to health outcomes.

Main Methods:

  • Utilized data from the Longitudinal Study of Australian Children (LSAC) (n=4934).
  • Classified child BMI using International Obesity TaskForce (IOTF) cutpoints.
  • Assessed health outcomes (global health, quality of life, mental health, asthma, sleep, injuries, special health care needs) and parental concern via parent-report, adjusting for sociodemographics.

Main Results:

  • 15.3% of children were overweight and 5.2% were obese.
  • Overweight and obese children had higher odds of special health care needs (aOR 1.72).
  • Parental concern was significantly higher in obese children (52.7%) but unrelated to specific health problems.

Conclusions:

  • Preschoolers with overweight/obesity experienced minimal additional health burdens reported by parents.
  • A notable gap exists between public concern and parental concern regarding their own child's weight status.
  • Findings highlight the need to address parental awareness and perception of childhood overweight/obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...